Stock TNXP TONIX PHARMACEUTICALS HOLDING CORP.
Add to a list
To use this feature you must be a member
Log inSign up

News Tonix Pharmaceuticals Holding Corp.

Equities

TNXP

US8902608475

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-06-28 EDT 		5-day change 1st Jan Change
0.6974 USD +1.07% Intraday chart for Tonix Pharmaceuticals Holding Corp. -46.35% -94.59%
06-28 Tonix Pharmaceuticals Closes $4 Million Offering MT
06-27 Top Midday Decliners MT

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Tonix Pharmaceuticals Closes $4 Million Offering
MT
Tonix Pharmaceuticals Announces Closing of $4.0 Million Public Offering
AQ
Top Midday Decliners
MT
Wall Street Set to Open Marginally Lower Thursday as Investors Parse Bullish Economic Data
MT
Tonix Pharmaceuticals Announces Pricing of Approximately $4.0 Million Public Offering
AQ
US Futures Trend Lower Pre-Bell as Investors Await Slew of Economic Data
MT
Top Premarket Decliners
MT
Tonix Pharmaceuticals Announces Proposed Public Offering
AQ
Tonix Pharmaceuticals Regains Compliance With Nasdaq Minimum Bid Price Rule
MT
Tonix Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement
AQ
Tonix Pharmaceuticals Presents Vaccine Platform Data in Keynote Talk at the Vaccine Congress 2024
AQ
Tonix Pharmaceuticals Holding Corp. Presents Vaccine Platform Data in Keynote Talk At the Vaccine Congress 2024
CI
Tonix Pharmaceuticals Announces Positive Pre-NDA CMC Meeting with FDA for Tonmya™ for the Management of Fibromyalgia
AQ
Tonix Pharmaceuticals Holding Corp. Announces Positive Pre-NDA CMC Meeting with FDA for Tonmya for the Management of Fibromyalgia
CI
Tonix Pharmaceuticals Presented Data Comparing Real-World Treatment of Migraine with Industry Guidelines for Non-Oral Products at the Annual Scientific Meeting of the American Headache Society
AQ
Tonix Pharmaceuticals Presented Poster of Tonmya for the Management of Fibromyalgia at the Annual European Congress of Rheumatology 2024
AQ
Tonix Pharmaceuticals Presented Data Comparing Real-World Treatment of Migraine with Industry Guidelines for Non-Oral Products at the Annual Scientific Meeting of the American Headache Society (AHS)
AQ
Tonix Pharmaceuticals Presented Poster of Tonmya™ for the Management of Fibromyalgia at the Annual European Congress of Rheumatology (EULAR) 2024
AQ
Tonix Pharmaceuticals Announces Closing of $4.0 Million Public Offering
AQ
Top Midday Decliners
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TNXP Stock
  4. News Tonix Pharmaceuticals Holding Corp.